From Nuforme

Nuforme research articles for practical ordering, clear payment expectations, and value-aware shopping.

Clinical trial documents and endpoint chart representing bremelanotide research in women.

Article

What Clinical Studies Say About Bremelanotide and Low Sexual Desire in Women

A close read of bremelanotide clinical studies in women: who was enrolled, what endpoints were measured, what improved, what did not, and why the data leave major gaps for perimenopause and menopause.

Read article

Abstract clinical trial comparison graphic showing two peptide structures and metabolic endpoint charts.

Article

Retatrutide vs Tirzepatide: Comparing the Latest Clinical Evidence

Retatrutide and tirzepatide are often compared, but the evidence is not evenly mature. This review looks at what human trials actually measured, where the endpoints overlap, and where the comparison stops.

Read article

Abstract laboratory data visualization representing NAD+ research and insulin sensitivity endpoints.

Article

NAD+ Research and Insulin Sensitivity: What Human Trials Actually Measured

Human trials of NAD+ precursors have measured blood NAD+ metabolites, skeletal-muscle signaling, and insulin sensitivity. The evidence is more interesting than simple wellness claims suggest—but thinner, and more sex-specific, than most readers are told.

Read article

Peptide vial beside a certificate of analysis with HPLC and mass spectrometry graphs on a clean laboratory bench

Article

Peptide Certificate of Analysis: How to Read One Before You Buy

A practical buyer’s guide to peptide COAs, HPLC purity, mass spectrometry, batch identity, and the supplier transparency signals that matter before purchasing research peptides in Canada.

Read article